Pediatric cardiomyopathy

Importance of genetic and metabolic evaluation

Steven J. Kindel, Erin M. Miller, Resmi Gupta, Linda H. Cripe, Robert B. Hinton, Robert L. Spicer, Jeffrey A. Towbin, Stephanie Ware

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Background: Cardiomyopathy is a heterogeneous disease with a strong genetic component. A research-based pediatric cardiomyopathy registry identified familial, syndromic, or metabolic causes in 30% of children. However, these results predated clinical genetic testing. Methods and Results: We determined the prevalence of familial, syndromic, or metabolic causes in 83 consecutive unrelated patients referred for genetic evaluation of cardiomyopathy from 2006 to 2009. Seventy-six percent of probands (n = 63) were categorized as familial, syndromic, or metabolic. Forty-three percent (n = 18) of hypertrophic cardiomyopathy (HCM) patients had mutations in sarcomeric genes, with MYH7 and MYBPC3 mutations predominating. Syndromic (17%; n = 7) and metabolic (26%; n = 11) causes were frequently identified in HCM patients. The metabolic subgroup was differentiated by decreased endocardial shortening fraction on echocardiography. Dilated cardiomyopathy (DCM) patients had similar rates of syndromic (20%; n = 5) and metabolic (16%; n = 4) causes, but fewer familial cases (24%; n = 6) compared with HCM patients. Conclusions: The cause of cardiomyopathy is identifiable in a majority of affected children. An underlying metabolic or syndromic cause is identified in >35% of children with HCM or DCM. Identification of etiology is important for management, family-based risk assessment, and screening.

Original languageEnglish (US)
Pages (from-to)396-403
Number of pages8
JournalJournal of Cardiac Failure
Volume18
Issue number5
DOIs
StatePublished - May 2012
Externally publishedYes

Fingerprint

Cardiomyopathies
Hypertrophic Cardiomyopathy
Pediatrics
Dilated Cardiomyopathy
Mutation
Genetic Testing
Registries
Echocardiography
Research
Genes

Keywords

  • Cardiomyopathy
  • genetic testing
  • genetics
  • heart failure
  • mutation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Kindel, S. J., Miller, E. M., Gupta, R., Cripe, L. H., Hinton, R. B., Spicer, R. L., ... Ware, S. (2012). Pediatric cardiomyopathy: Importance of genetic and metabolic evaluation. Journal of Cardiac Failure, 18(5), 396-403. https://doi.org/10.1016/j.cardfail.2012.01.017

Pediatric cardiomyopathy : Importance of genetic and metabolic evaluation. / Kindel, Steven J.; Miller, Erin M.; Gupta, Resmi; Cripe, Linda H.; Hinton, Robert B.; Spicer, Robert L.; Towbin, Jeffrey A.; Ware, Stephanie.

In: Journal of Cardiac Failure, Vol. 18, No. 5, 05.2012, p. 396-403.

Research output: Contribution to journalArticle

Kindel, SJ, Miller, EM, Gupta, R, Cripe, LH, Hinton, RB, Spicer, RL, Towbin, JA & Ware, S 2012, 'Pediatric cardiomyopathy: Importance of genetic and metabolic evaluation', Journal of Cardiac Failure, vol. 18, no. 5, pp. 396-403. https://doi.org/10.1016/j.cardfail.2012.01.017
Kindel SJ, Miller EM, Gupta R, Cripe LH, Hinton RB, Spicer RL et al. Pediatric cardiomyopathy: Importance of genetic and metabolic evaluation. Journal of Cardiac Failure. 2012 May;18(5):396-403. https://doi.org/10.1016/j.cardfail.2012.01.017
Kindel, Steven J. ; Miller, Erin M. ; Gupta, Resmi ; Cripe, Linda H. ; Hinton, Robert B. ; Spicer, Robert L. ; Towbin, Jeffrey A. ; Ware, Stephanie. / Pediatric cardiomyopathy : Importance of genetic and metabolic evaluation. In: Journal of Cardiac Failure. 2012 ; Vol. 18, No. 5. pp. 396-403.
@article{a1d9d7d5823c410f9a5c1ed94681a4f8,
title = "Pediatric cardiomyopathy: Importance of genetic and metabolic evaluation",
abstract = "Background: Cardiomyopathy is a heterogeneous disease with a strong genetic component. A research-based pediatric cardiomyopathy registry identified familial, syndromic, or metabolic causes in 30{\%} of children. However, these results predated clinical genetic testing. Methods and Results: We determined the prevalence of familial, syndromic, or metabolic causes in 83 consecutive unrelated patients referred for genetic evaluation of cardiomyopathy from 2006 to 2009. Seventy-six percent of probands (n = 63) were categorized as familial, syndromic, or metabolic. Forty-three percent (n = 18) of hypertrophic cardiomyopathy (HCM) patients had mutations in sarcomeric genes, with MYH7 and MYBPC3 mutations predominating. Syndromic (17{\%}; n = 7) and metabolic (26{\%}; n = 11) causes were frequently identified in HCM patients. The metabolic subgroup was differentiated by decreased endocardial shortening fraction on echocardiography. Dilated cardiomyopathy (DCM) patients had similar rates of syndromic (20{\%}; n = 5) and metabolic (16{\%}; n = 4) causes, but fewer familial cases (24{\%}; n = 6) compared with HCM patients. Conclusions: The cause of cardiomyopathy is identifiable in a majority of affected children. An underlying metabolic or syndromic cause is identified in >35{\%} of children with HCM or DCM. Identification of etiology is important for management, family-based risk assessment, and screening.",
keywords = "Cardiomyopathy, genetic testing, genetics, heart failure, mutation",
author = "Kindel, {Steven J.} and Miller, {Erin M.} and Resmi Gupta and Cripe, {Linda H.} and Hinton, {Robert B.} and Spicer, {Robert L.} and Towbin, {Jeffrey A.} and Stephanie Ware",
year = "2012",
month = "5",
doi = "10.1016/j.cardfail.2012.01.017",
language = "English (US)",
volume = "18",
pages = "396--403",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "5",

}

TY - JOUR

T1 - Pediatric cardiomyopathy

T2 - Importance of genetic and metabolic evaluation

AU - Kindel, Steven J.

AU - Miller, Erin M.

AU - Gupta, Resmi

AU - Cripe, Linda H.

AU - Hinton, Robert B.

AU - Spicer, Robert L.

AU - Towbin, Jeffrey A.

AU - Ware, Stephanie

PY - 2012/5

Y1 - 2012/5

N2 - Background: Cardiomyopathy is a heterogeneous disease with a strong genetic component. A research-based pediatric cardiomyopathy registry identified familial, syndromic, or metabolic causes in 30% of children. However, these results predated clinical genetic testing. Methods and Results: We determined the prevalence of familial, syndromic, or metabolic causes in 83 consecutive unrelated patients referred for genetic evaluation of cardiomyopathy from 2006 to 2009. Seventy-six percent of probands (n = 63) were categorized as familial, syndromic, or metabolic. Forty-three percent (n = 18) of hypertrophic cardiomyopathy (HCM) patients had mutations in sarcomeric genes, with MYH7 and MYBPC3 mutations predominating. Syndromic (17%; n = 7) and metabolic (26%; n = 11) causes were frequently identified in HCM patients. The metabolic subgroup was differentiated by decreased endocardial shortening fraction on echocardiography. Dilated cardiomyopathy (DCM) patients had similar rates of syndromic (20%; n = 5) and metabolic (16%; n = 4) causes, but fewer familial cases (24%; n = 6) compared with HCM patients. Conclusions: The cause of cardiomyopathy is identifiable in a majority of affected children. An underlying metabolic or syndromic cause is identified in >35% of children with HCM or DCM. Identification of etiology is important for management, family-based risk assessment, and screening.

AB - Background: Cardiomyopathy is a heterogeneous disease with a strong genetic component. A research-based pediatric cardiomyopathy registry identified familial, syndromic, or metabolic causes in 30% of children. However, these results predated clinical genetic testing. Methods and Results: We determined the prevalence of familial, syndromic, or metabolic causes in 83 consecutive unrelated patients referred for genetic evaluation of cardiomyopathy from 2006 to 2009. Seventy-six percent of probands (n = 63) were categorized as familial, syndromic, or metabolic. Forty-three percent (n = 18) of hypertrophic cardiomyopathy (HCM) patients had mutations in sarcomeric genes, with MYH7 and MYBPC3 mutations predominating. Syndromic (17%; n = 7) and metabolic (26%; n = 11) causes were frequently identified in HCM patients. The metabolic subgroup was differentiated by decreased endocardial shortening fraction on echocardiography. Dilated cardiomyopathy (DCM) patients had similar rates of syndromic (20%; n = 5) and metabolic (16%; n = 4) causes, but fewer familial cases (24%; n = 6) compared with HCM patients. Conclusions: The cause of cardiomyopathy is identifiable in a majority of affected children. An underlying metabolic or syndromic cause is identified in >35% of children with HCM or DCM. Identification of etiology is important for management, family-based risk assessment, and screening.

KW - Cardiomyopathy

KW - genetic testing

KW - genetics

KW - heart failure

KW - mutation

UR - http://www.scopus.com/inward/record.url?scp=84860457415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860457415&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2012.01.017

DO - 10.1016/j.cardfail.2012.01.017

M3 - Article

VL - 18

SP - 396

EP - 403

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 5

ER -